Table 1.
Group A (benign breast disease) | Group B (breast cancer patients) | |
---|---|---|
Number of patients |
6 |
10 |
Median age (years) |
37 (range, 28–47) |
55 (range, 36–76) |
Disease |
Fibroadenoma |
Invasive ductal carcinoma |
Disease site | ||
Right breast |
3/6 |
8/10 |
Left breast |
3/6 |
2/10 |
Surgical procedure | ||
WLE |
6/6 |
- |
WLE + ALND |
- |
5/10 |
MRM + ALND |
- |
5/10 |
T stage | ||
T1 |
- |
0/10 |
T2 |
- |
5/10 |
T3 |
- |
5/10 |
N status | ||
N0 |
- |
6/10 |
N1 |
- |
3/10 |
N2 |
- |
1/10 |
Grade | ||
2 |
- |
9/10 |
3 |
- |
1/10 |
Hormonal receptor status | ||
ER+ |
- |
10/10 |
PR+ |
- |
10/10 |
HER2 status | ||
0 |
- |
4/10 |
1 |
- |
2/10 |
2 |
- |
4/10 |
Blood samples | PRE, day 3 | PRE, day 3, day 7 |
ALND axillary lymph node dissection, ER estrogen receptors, MRM modified radical mastectomy, PR progesterone receptors, PRE day before surgery, WLE wide local excision.